Operating Lease, Right-of-Use Asset of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TC BioPharm (Holdings) plc quarterly Operating Lease, Right-of-Use Asset in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was £1,132,816, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (GBP)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Operating Lease, Right-of-Use Asset (GBP)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 £1,132,816 -£207,953 -16% 31 Dec 2024 20-F 09 May 2025 2024 FY
Q2 2024 £1,241,026 30 Jun 2024 6-K 25 Nov 2024 2024 Q2
Q1 2024 £1,292,708 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 £1,340,769 -£189,505 -12% 31 Dec 2023 20-F 09 May 2025 2024 FY
Q4 2022 £1,530,274 31 Dec 2022 10-K 01 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.